T1	Participants 103 149	acute bacterial maxillary sinusitis in adults.
T2	Participants 229 323	outpatients with both clinical signs and symptoms and radiographic evidence of acute sinusitis
T3	Participants 501 552	452 patients considered valid for clinical efficacy
